文献速递胸部肿瘤

第二原发肺癌的风险分层

Risk Stratification for Second Primary Lung Cancer.
PubMed 文献 · J Clin Oncol · 2017-06-23

该研究基于SEER数据库中20,032例1988至2003年确诊且生存≥5年的初治原发性肺癌(IPLC)幸存者,用比例亚分布风险模型估计10年第二原发肺癌(SPLC)风险。幸存者10年SPLC风险中位数为8.36%,按年龄、组织学和IPLC范围分层后风险范围为0.56%至14.3%,决策曲线分析显示风险阈值1%至11.5%时模型净获益优于全筛查或无筛查。作者认为该风险分层方法可能有助于识别需CT筛查的肺癌幸存者。

要点

  • 20,032例IPLC幸存者10年SPLC风险中位数为8.36%,分层后范围为0.56%至14.3%。
  • 风险十分位第十组SPLC观察发生率12.5%,第一组2.9%(P < 10-10)。
  • 决策曲线分析显示风险阈值1%至11.5%时模型临床净获益大于全筛查或无筛查。

核心结论

  • SPLC的风险分层方法可能有助于识别需接受计算机断层扫描(CT)筛查的肺癌幸存者。
  • 更全面的环境和遗传数据可能有助于增强SPLC风险模型的预测能力和分层能力。

研究设计与样本

  • 基于SEER数据的基于人群的队列研究,纳入20,032例1988至2003年确诊且初始诊断后生存≥5年的IPLC患者。
  • 采用比例亚分布风险模型在竞争风险存在下估计肺癌幸存者10年SPLC风险,考虑预测因素包括年龄、性别、种族、治疗、组织学、分期和疾病范围。
  • 评估预测模型的风险分层能力,并进行决策曲线分析,通过计算不同筛查风险阈值下的净获益评估模型临床效用。

主要发现

  • 肺癌幸存者10年SPLC风险中位数为8.36%,最终预测模型按年龄、组织学和IPLC范围分层后估计风险范围为0.56%至14.3%。
  • 按估计风险十分位分层,第十十分位组SPLC观察发生率12.5%,第一十分位组2.9%(P < 10-10)。
  • 决策曲线分析得出风险阈值范围1%至11.5%,在该范围内风险模型的临床净获益大于假设的全筛查或无筛查场景。

关键数值与推荐

  • 10年SPLC风险中位数8.36%,分层后范围0.56%至14.3%。
  • 第十十分位组SPLC观察发生率12.5% vs 第一十分位组2.9%(P < 10-10)。
  • 决策曲线分析净获益优于全筛查或无筛查的风险阈值范围为1%至11.5%。

临床怎么用

  • 作者认为SPLC风险分层方法可能有助于识别需接受CT筛查的肺癌幸存者。
  • 作者指出更全面的环境和遗传数据可能有助于增强风险模型对SPLC的预测能力和分层能力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose This study estimated the 10-year risk of developing second primary lung cancer (SPLC) among survivors of initial primary lung cancer (IPLC) and evaluated the clinical utility of the risk prediction model for selecting eligibility criteria for screening. Methods SEER data were used to identify a population-based cohort of 20,032 participants diagnosed with IPLC between 1988 and 2003 and who survived ≥ 5 years after the initial diagnosis. We used a proportional subdistribution hazards model to estimate the 10-year risk of developing SPLC among survivors of lung cancer LC in the presence of competing risks. Considered predictors included age, sex, race, treatment, histology, stage, and extent of disease. We examined the risk-stratification ability of the prediction model and performed decision curve analysis to evaluate the clinical utility of the model by calculating its net benefit in varied risk thresholds for screening. Results Although the median 10-year risk of SPLC among survivors of LC was 8.36%, the estimated risk varied substantially (range, 0.56% to 14.3%) when stratified by age, histology, and extent of IPLC in the final prediction model. The stratification by deciles of estimated risk showed that the observed incidence of SPLC was significantly higher in the tenth-decile group (12.5%) versus the first-decile group (2.9%; P < 10-10). The decision curve analysis yielded a range of risk thresholds (1% to 11.5%) at which the clinical net benefit of the risk model was larger than those in hypothetical all-screening or no-screening scenarios. Conclusion The risk stratification approach in SPLC can be potentially useful for identifying survivors of LC to be screened by computed tomography. More comprehensive environmental and genetic data may help enhance the predictability and stratification ability of the risk model for SPLC.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Han SS, Rivera GA, Tammemägi MC, et al. Risk Stratification for Second Primary Lung Cancer. J Clin Oncol. 2017. PMID: 28644772. doi:10.1200/JCO.2017.72.4203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。